Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

At Close

Jan 21, 2026 3:59:55 PM EST

135.43USD+0.662%(+0.89)927,284

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-134.54)0

After-hours

Jan 21, 2026 4:05:30 PM EST

134.00USD-1.056%(-1.43)33,085

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

13.51B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Feb 5, 2026 (14d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

1,230,363

Avg. Vol. 30 Day

1,103,036

Employees

470

Market Cap

13,507,130,908

Shares Out.

99,705,698

On/Off Exchange

62%/38%

6 Month Beta

0.58

1 Year Beta

0.83

2 Year Beta

0.75

3 Year Beta

0.68

52 Week Low

84.23

52 Week High

160.18

SMA50

144.40

SMA200

132.49

1 Week

+1.59%

1 Month

-8.18%

3 Month

-4.24%

6 Month

+2.05%

1 Year

-7.69%

2 Year

-3.10%

5 Year

+15.88%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $135.43, and today's volume is 927,284. NBIX is up 0.662% today. The 30 day average volume is 1,103,036. NBIX market cap is 13.51B with 99,705,698 shares outstanding.